Emerging biomarkers for heart failure: an update

Dalzell, J. R., Cannon, J. A., Jackson, C. E., Lang, N. N. and Gardner, R. S. (2014) Emerging biomarkers for heart failure: an update. Biomarkers in Medicine, 8(6), pp. 833-840. (doi: 10.2217/bmm.14.51) (PMID:25224939)

Full text not currently available from Enlighten.


A growing array of biological pathways underpins the syndrome we recognize as heart failure. These include both deleterious pathways promoting its development and progression, as well as compensatory cardioprotective pathways. Components of these pathways can be utilized as biomarkers of this condition to aid diagnosis, prognostication and potentially guide management. As our understanding of the pathophysiology of heart failure deepens further candidate biomarkers are being identified. We provide an overview of the more recently emerging biomarkers displaying potential promise for future clinical use.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Gardner, Professor Roy and Lang, Professor Ninian and Jackson, Dr Colette and Dalzell, Dr Jonathan and Cannon, Dr Jane
Authors: Dalzell, J. R., Cannon, J. A., Jackson, C. E., Lang, N. N., and Gardner, R. S.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Biomarkers in Medicine
Publisher:Future Medicine Ltd.
ISSN (Online):1752-0371

University Staff: Request a correction | Enlighten Editors: Update this record